JPRN-UMIN000001541已完成未知
Phase II trial of combination chemotherapy consisting of S-1 and Oxaliplatin in patients with advanced or recurrent mucinous adenocarcinoma of the ovary - MOST trial
Japan ovarian mucinous adenocarcinoma study group0 个研究点目标入组 40 人开始时间: 2009年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Patients having fever over 38.0 2.Patients with infection or more than WBC:12,000/mm3 3.Patients with severe complications 4.Patients with double cancer 5.Patients with massive pleural effusion, ascites and pericardial fluid need to continuous drainage 6.Patients with severe paresthesia with functional disorder, or dysesthesia 7.Patients who cannot undergo treatment due to the past history of mental disorder or the central nerve disorder 8.Patients with brain metastasis 9.Patients with more than grade 3 diarrhea. More than grade 2 diarrhea in patients receiving colostomy.
研究者
相似试验
已完成
不适用
Phase II trial of combination chemotherapy consisting of pegylated liposomal doxorubicin and carboplatin in patients with recurrent ovarian cancerEpithelial ovarian cancer, primary fallopian tube cancer, or peritoneal cancer in late relapse (>6 months) after 1st-line chemotherapyJPRN-UMIN000002691Keio University, School of Medicine33
已完成
2 期
Phase II clinical trial of combination chemotherapy with bendamustine and rituximab for relapsed or refractory CD20 positive indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma patientsCD20 positive indolent B-cell non-Hodgkin lymphoma and mantle cell lymphomaJPRN-UMIN000008024Kyoto University Hematology Study Group45
进行中（未招募）
不适用
Klinisk prövning med kombinationsbehandling av kemoterapi och antikroppar för behandling av patienter med gallgångscancer som inte kan opereras.EUCTR2010-020385-13-SEVejle Hospital78
进行中（未招募）
1 期
Randomized phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable cholangiocarcinoma without KRAS mutations - GOC-B-PEUCTR2010-020385-13-DKVejle Hospital
招募中
1 期
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancerRectal cancerJPRN-UMIN000002602Yokohama City University Graduate School of Medicine35